NASDAQ: PHLT
Performant Healthcare Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their PHLT stock forecasts and price targets.

Forecast return on equity

Is PHLT forecast to generate an efficient return?

Company
6.01%
Industry
37.69%
Market
56.76%
PHLT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PHLT forecast to generate an efficient return on assets?

Company
4.46%
Industry
14.58%
PHLT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PHLT earnings per share forecast

What is PHLT's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.05
Avg 2 year Forecast
$0.06

PHLT revenue forecast

What is PHLT's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$134.2M+4.1%
Avg 2 year Forecast
$149.0M+15.58%
PHLT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PHLT revenue growth forecast

How is PHLT forecast to perform vs Specialty Business Services companies and vs the US market?

Company
4.1%
Industry
3.85%
Market
55.62%
PHLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PHLT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PHLT vs Specialty Business Service Stocks

TickerPricePrice TargetUp/downsideConsensus
PHLT$3.25N/AN/A
QUAD$5.25$9.45+80.00%Strong Buy
RHLD$32.80N/AN/A
CVEO$22.26$27.00+21.29%Strong Buy
SPIR$10.90$15.67+43.73%Strong Buy

Performant Healthcare Stock Forecast FAQ

What is PHLT's earnings growth forecast for 2025-2026?

(NASDAQ: PHLT) Performant Healthcare's forecast annual earnings growth rate of N/A is not forecast to beat the US Specialty Business Services industry's average forecast earnings growth rate of 17.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.

Performant Healthcare's earnings in 2025 is -$5,959,000.On average, 1 Wall Street analyst forecast PHLT's earnings for 2025 to be -$3,915,432, with the lowest PHLT earnings forecast at -$3,915,432, and the highest PHLT earnings forecast at -$3,915,432.

In 2026, PHLT is forecast to generate $4,698,518 in earnings, with the lowest earnings forecast at $4,698,518 and the highest earnings forecast at $4,698,518.

If you're new to stock investing, here's how to buy Performant Healthcare stock.

What is PHLT's revenue growth forecast for 2025-2026?

(NASDAQ: PHLT) Performant Healthcare's forecast annual revenue growth rate of 4.1% is forecast to beat the US Specialty Business Services industry's average forecast revenue growth rate of 3.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.62%.

Performant Healthcare's revenue in 2025 is $128,916,000.On average, 1 Wall Street analysts forecast PHLT's revenue for 2025 to be $10,509,019,488, with the lowest PHLT revenue forecast at $10,509,019,488, and the highest PHLT revenue forecast at $10,509,019,488.

In 2026, PHLT is forecast to generate $11,667,987,360 in revenue, with the lowest revenue forecast at $11,667,987,360 and the highest revenue forecast at $11,667,987,360.

What is PHLT's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: PHLT) forecast ROA is 4.46%, which is lower than the forecast US Specialty Business Services industry average of 14.58%.

What is PHLT's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: PHLT) Performant Healthcare's current Earnings Per Share (EPS) is -$0.08. On average, analysts forecast that PHLT's EPS will be -$0.05 for 2025, with the lowest EPS forecast at -$0.05, and the highest EPS forecast at -$0.05. In 2026, PHLT's EPS is forecast to hit $0.06 (min: $0.06, max: $0.06).

What is PHLT's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: PHLT) forecast ROE is 6.01%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.